Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Methadone and buprenorphine added to the WHO list of essential medicines.

Literature DB >> 16544403

Methadone and buprenorphine added to the WHO list of essential medicines.

Abstract

In March 2005, methadone and buprenorphine were recently added as "complimentary" medicines to the 14th Model List of Essential Medicines (LEM) released by the World Health Organization (WHO). Studies have shown that these drugs increase adherence to antiretroviral therapy as well as reduce the risk of HIV infection among injection drug users (IDUs).

Entities: Chemical Disease

Mesh：

Substances：

Year: 2005 PMID： 16544403

Source DB: PubMed Journal: HIV AIDS Policy Law Rev ISSN： 1712-624X

Keyword Cloud
Cited

20 in total

Review 1. The State of Opioid Agonist Therapy in Canada 20 Years after Federal Oversight.

Authors: Joseph K Eibl; Kristen Morin; Esa Leinonen; David C Marsh
Journal: Can J Psychiatry Date: 2017-05-19 Impact factor: 4.356

2. Impact of incarceration on rates of methadone use in a community recruited cohort of injection drug users.

Authors: John D Koehn; Paxton Bach; Kanna Hayashi; Paul Nguyen; Thomas Kerr; M-J Milloy; Launette Rieb; Evan Wood
Journal: Addict Behav Date: 2015-02-13 Impact factor: 3.913

3. Evaluation of a Dual Fentanyl/Heroin Vaccine on the Antinociceptive and Reinforcing Effects of a Fentanyl/Heroin Mixture in Male and Female Rats.

Authors: E Andrew Townsend; Paul T Bremer; Kaycee E Faunce; S Stevens Negus; Alaina M Jaster; Hannah L Robinson; Kim D Janda; Matthew L Banks
Journal: ACS Chem Neurosci Date: 2020-04-22 Impact factor: 4.418

8. Ethnic- and gender-specific differences in the prevalence of HIV among patients in opioid maintenance treatment-a case register analysis.

Authors: Michael Liebrenz; Rudolf Stohler; Carlos Nordt
Journal: Harm Reduct J Date: 2014-08-18

9. The opioid crisis: past, present and future policy climate in Ontario, Canada.

Authors: Kristen A Morin; Joseph K Eibl; Alexandra M Franklyn; David C Marsh
Journal: Subst Abuse Treat Prev Policy Date: 2017-11-02

Review 10. The long winding road of opioid substitution therapy implementation in South-East Asia: challenges to scale up.

Authors: Gary Reid; Mukta Sharma; Peter Higgs
Journal: J Public Health Res Date: 2014-03-26

Methadone and buprenorphine added to the WHO list of essential medicines.

Review 1. The State of Opioid Agonist Therapy in Canada 20 Years after Federal Oversight.

2. Impact of incarceration on rates of methadone use in a community recruited cohort of injection drug users.

3. Evaluation of a Dual Fentanyl/Heroin Vaccine on the Antinociceptive and Reinforcing Effects of a Fentanyl/Heroin Mixture in Male and Female Rats.

4. The lasting impact of methocinnamox on opioid self-administration.

Review 5. The medical management of opioid dependence in HIV primary care settings.

6. Emergence of methadone as a street drug in St. Petersburg, Russia.

7. A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease.

8. Ethnic- and gender-specific differences in the prevalence of HIV among patients in opioid maintenance treatment-a case register analysis.

9. The opioid crisis: past, present and future policy climate in Ontario, Canada.

Review 10. The long winding road of opioid substitution therapy implementation in South-East Asia: challenges to scale up.